Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,038 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.
Kamiunten A, Shide K, Kameda T, Sekine M, Kubuki Y, Ito M, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Akizuki K, Tahira Y, Shimoda H, Hidaka T, Yamashita K, Matsuoka H, Shimoda K. Kamiunten A, et al. Among authors: ito m. Int J Hematol. 2018 Jun;107(6):681-688. doi: 10.1007/s12185-018-2428-0. Epub 2018 Feb 27. Int J Hematol. 2018. PMID: 29488167
Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
Goto T, Ikuta K, Inamoto Y, Kamoshita S, Yokohata E, Koyama D, Onodera K, Seto A, Watanabe K, Imahashi N, Tsukamoto S, Ozawa Y, Sasaki K, Ito M, Kohgo Y, Miyamura K. Goto T, et al. Among authors: ito m. Int J Hematol. 2013 Jan;97(1):125-34. doi: 10.1007/s12185-012-1252-1. Epub 2012 Dec 23. Int J Hematol. 2013. PMID: 23264147
Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia.
Kamiunten A, Shide K, Kameda T, Ito M, Sekine M, Kubuki Y, Hidaka T, Akizuki K, Tahira Y, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Shimoda H, Yamashita K, Matsuoka H, Shimoda K. Kamiunten A, et al. Among authors: ito m. Int J Hematol. 2018 Oct;108(4):411-415. doi: 10.1007/s12185-018-2495-2. Epub 2018 Jul 9. Int J Hematol. 2018. PMID: 29987745
Essential thrombocytosis attributed to JAK2-T875N germline mutation.
Yoshimitsu M, Hachiman M, Uchida Y, Arima N, Arai A, Kamada Y, Shide K, Ito M, Shimoda K, Ishitsuka K. Yoshimitsu M, et al. Among authors: ito m. Int J Hematol. 2019 Nov;110(5):584-590. doi: 10.1007/s12185-019-02725-8. Epub 2019 Aug 19. Int J Hematol. 2019. PMID: 31428969
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
Edahiro Y, Ohishi K, Gotoh A, Takenaka K, Shibayama H, Shimizu T, Usuki K, Shimoda K, Ito M, VanWart SA, Zagrijtschuk O, Qin A, Kawase H, Miyachi N, Sato T, Komatsu N, Kirito K. Edahiro Y, et al. Among authors: ito m. Int J Hematol. 2022 Aug;116(2):215-227. doi: 10.1007/s12185-022-03341-9. Epub 2022 Apr 16. Int J Hematol. 2022. PMID: 35430707 Clinical Trial.
Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
Edahiro Y, Ohishi K, Gotoh A, Takenaka K, Shibayama H, Shimizu T, Usuki K, Shimoda K, Ito M, VanWart SA, Zagrijtschuk O, Qin A, Kawase H, Miyachi N, Sato T, Komatsu N, Kirito K. Edahiro Y, et al. Among authors: ito m. Int J Hematol. 2022 Oct;116(4):642-643. doi: 10.1007/s12185-022-03440-7. Int J Hematol. 2022. PMID: 36029457 No abstract available.
11,038 results
You have reached the last available page of results. Please see the User Guide for more information.